切换导航
关闭
  • 菜单
  • Setting

Signaling Pathways - Calpains - Valosin-containing protein (VCP) - Inward Rectifier Potassium (Kir) Channels - Animal Experiments

10 件产品

每页
清除全部
  1. Nateglinide
    B2198 Nateglinide
    中文名: 那格列奈
    Target: Inward Rectifier Potassium (Kir) Channels
    Summary: 胰岛素促分泌剂
      ≥16.4 mg/mL
      insoluble in H2O
  2. Gliclazide
    B2195 Gliclazide
    中文名: 格列齐特
    Target: Inward Rectifier Potassium (Kir) Channels
    Summary: 钾通道抑制剂
      ≥15.6 mg/mL
      insoluble in H2O
  3. Mitiglinide Calcium
    B2193 Mitiglinide Calcium
    中文名: 米格列奈钙
    Target: Inward Rectifier Potassium (Kir) Channels
    Summary: 钾通道抑制剂
      ≥33.45 mg/mL
      insoluble in H2O
  4. Glibenclamide
    B1296 Glibenclamide
    中文名: 格列本脲
    Target: Inward Rectifier Potassium (Kir) Channels
    Summary: 胰岛素生产调节剂
      ≥49.4 mg/mL
      insoluble in H2O
  5. Terfenadine
    A8534 Terfenadine
    中文名: 特非那定
    Target: Voltage-gated Potassium (KV) Channels|Histamine H1 Receptors|Inward Rectifier Potassium (Kir) Channels
    Summary: 组胺H1受体拮抗剂
      ≥18 mg/mL
      insoluble in H2O
  6. PD 150606
    A4413 PD 150606
    Target: Calpains
    Summary: 非肽类钙蛋白酶抑制剂
      Soluble in DMSO
  7. MDL 28170
    A4412 MDL 28170
    Target: Cathepsins|Calpains
    Summary: Calpain和cathepsin B抑制剂
      ≥16.75 mg/mL
      insoluble in H2O
  8. Calpain Inhibitor I, ALLN
    A2602 Calpain Inhibitor I, ALLN
     2 Citation
    Target: Cathepsins|Calpains
    Summary: Calpain I/II/ B/L抑制剂
      ≥19.1 mg/mL
      insoluble in H2O
  9. E-64
    A2576 E-64
     2 Citation
    Target: Cathepsins|Calpains|Papains
    Summary: 半胱氨酸蛋白酶(cysteine protease)抑制剂
      ≥53.6 mg/mL
      ≥49.1 mg/mL
  10. Leupeptin, Microbial
    A2570 Leupeptin, Microbial
    中文名: 亮抑酶肽
    Target: Cathepsins|Calpains|Trypsins
    Summary: 丝氨酸和半胱氨酸蛋白酶抑制剂
      ≥24.7 mg/mL
      ≥54.4 mg/mL

10 件产品

每页